Intratumoral injection of an adenovirus expressing interleukin 2 induces regression and immunity in a murine breast cancer model.

Rodent tumor cells engineered to secrete cytokines such as interleukin 2 (IL-2) or IL-4 are rejected by syngeneic recipients due to an enhanced antitumor host immune response. An adenovirus vector (AdCAIL-2) containing the human IL-2 gene has been constructed and shown to direct secretion of high le...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

I whakaputaina i:	Proc Natl Acad Sci U S A
Ngā kaituhi matua:	Addison, C L, Braciak, T, Ralston, R, Muller, W J, Gauldie, J, Graham, F L
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	National Academy of Sciences 1995
Ngā marau:	Research Article
Urunga tuihono:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC41189/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7667323/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.92.18.8522
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!